Kumar Singh

Kumar joined Allele in 2020 focused on raising capital for promising life science companies through the executing broker-dealer. Kumar has developed extensive relationships with accredited and institutional investors who seek early access to innovative science that can translate into therapeutic solutions to treat disease. Previously, he served as a broker at Noble Capital Markets, where he raised money for emerging companies in their Life Science Division. Prior to Noble, he was an Investment Associate at Paulson Investment Company, where he raised capital for private and public companies in biotechnology, medical device and real estate. He has helped finance a dozen companies in therapeutic categories ranging from diabetes to oncology.​​

Kumar studied Business Administration at Northeastern University. He serves on Wilmington Capital Securities’ Equity Capital Life Sciences Division and holds FINRA series 7 and 63 licenses.